-
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboxamide
-
ChemBase ID:
72801
-
Molecular Formular:
C22H24N2O9
-
Molecular Mass:
460.43396
-
Monoisotopic Mass:
460.14818036
-
SMILES and InChIs
SMILES:
C1(=C([C@H]([C@H]2[C@@](C1=O)(C(=O)C1=C(c3c([C@]([C@H]1[C@@H]2O)(O)C)cccc3O)O)O)N(C)C)O)C(=O)N
Canonical SMILES:
CN([C@@H]1C(=C(C(=O)N)C(=O)[C@@]2([C@H]1[C@@H](O)[C@H]1C(=C(O)c3c([C@@]1(C)O)cccc3O)C2=O)O)O)C
InChI:
InChI=1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-28,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1
InChIKey:
JLGOGFIHBRJQHY-PXOLEDIWSA-N
-
Cite this record
CBID:72801 http://www.chembase.cn/molecule-72801.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene-2-carboxamide
|
|
|
IUPAC Traditional name
|
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy-6-methyl-1,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide
|
|
|
Synonyms
|
Terramycin
|
Liquamycin
|
Oxytetracycline
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
0.2717006
|
H Acceptors
|
10
|
H Donor
|
7
|
LogD (pH = 5.5)
|
-4.791391
|
LogD (pH = 7.4)
|
-5.624763
|
Log P
|
-4.764702
|
Molar Refractivity
|
115.3049 cm3
|
Polarizability
|
43.96009 Å3
|
Polar Surface Area
|
201.85 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
false
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
Storage Condition
|
-20°C
|
Show
data source
|
|
Salt Data
|
Free Base
|
Show
data source
|
|
DETAILS
DETAILS
Selleck Chemicals
Selleck Chemicals -
S1773
|
Research Area: Infection Biological Activity: Oxytetracycline(Terramycin) was the second of the broad-spectrum tetracycline group of antibiotics to be discovered. Oxytetracycline works by interfering with the ability of bacteria to produce proteins that are essential to them. Without these proteins the bacteria cannot grow, multiply and increase in numbers. Oxytetracycline therefore stops the spread of the infection and the remaining bacteria are killed by the immune system or eventually die. Oxytetracycline is a broad spectrum antibiotic that is active against a wide variety of bacteria. Oxytetracycline is still used to treat infections caused by chlamydia (e.g. the chest infection psittacosis, the eye infection trachoma, and the genital infection urethritis) and infections caused by mycoplasma organisms. [1] |
PATENTS
PATENTS
PubChem Patent
Google Patent